Azalive 100 mg Injection
$57.15
$44.58
Azalive 100 mg Injection is a targeted anticancer therapy specifically formulated for the treatment of myelodysplastic syndrome (MDS), a condition characterized by the production of dysfunctional blood cells in the bone marrow, resulting in insufficient healthy blood cell counts. This medication belongs to the demethylation agent class, functioning by blocking DNA methylation, a crucial process that can disrupt normal gene expression and lead to cellular abnormalities. By effectively halting this methylation, Azalive aids in restoring proper gene function, promoting the formation of healthy blood cells while simultaneously eliminating the harmful cells within the bone marrow. Patients receiving Azalive should be aware of potential side effects and consult their healthcare provider for guidance regarding its use, especially if they have pre-existing conditions or are taking other medications. This injection not only supports blood cell health but also plays a vital role in managing the complications associated with MDS. Azalive 100 mg is administered under professional supervision to ensure optimal efficacy and safety. For anyone navigating the challenges of myelodysplastic syndrome, Azalive represents a significant advancement in the pursuit of healthier blood cell production and overall well-being.
Quantity
Active Pharmaceutical Ingredient
Uses
• Azalive 100 mg injection is primarily used to treat myelodysplastic syndromes (MDS), a group of disorders affecting bone marrow function. In patients with MDS, the bone marrow produces abnormal and immature blood cells, known as blasts. These immature cells do not perform effectively, resulting in symptoms such as anemia and increased susceptibility to infections. By addressing the underlying issues associated with MDS, Azalive 100 mg injection helps improve blood cell production.
• The administration of Azalive 100 mg injection aims to promote the maturation of blood cells in individuals diagnosed with myelodysplastic syndromes. This medication assists in reducing the proportion of ineffective blasts in the bone marrow. As a result, patients may experience better blood cell counts and a decrease in related symptoms. Azalive 100 mg injection plays a crucial role in managing the complications associated with these blood disorders.
• Patients receiving Azalive 100 mg injection may notice an improvement in their overall quality of life as it addresses the effects of myelodysplastic syndromes. This treatment can help alleviate symptoms such as fatigue, weakness, and bleeding tendencies caused by inadequate blood cell production. By enhancing the bone marrow's ability to generate healthy blood cells, Azalive 100 mg injection supports patients in managing their condition more effectively. Regular use of this injection may lead to more stable blood counts over time.
• Azalive 100 mg injection is often utilized as part of a comprehensive treatment plan for individuals with myelodysplastic syndromes. It is usually administered in conjunction with other supportive therapies to optimize patient outcomes. The injection not only targets the abnormal cell production but also aims to improve the overall health of the bone marrow. Through its targeted action, Azalive 100 mg injection helps to mitigate the complications associated with MDS, fostering better patient management.
Benefits
Azalive 100 mg Injection is an anti-cancer drug that is used to treat various types of cancers, including leukemia, lymphoma, and myelodysplastic syndromes. Its main benefit is that it works by interfering with the growth of cancer cells, which can help to slow down or stop the growth of tumors. In addition to reducing the size of tumors. Azalive 100 mg Vial can also improve blood counts in patients with myelodysplastic syndromes by stimulating the production of healthy blood cells in the bone marrow. This can help to reduce symptoms such as anemia, fatigue, and increased risk of infections. Furthermore, by slowing down or stopping the growth of cancer cells, Azalive 100 mg can help to reduce the risk of disease progression in patients with cancer. Azalive 100 mg Injection is administered either intravenously or intramuscularly, which makes it a convenient treatment option for patients who may have difficulty taking oral medications.
Side Effects
Like all medications, Azalive Injection for cancer can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Constipation
• Joint Pain
• Rashes
• Tiredness
• Stomach Pain
• Nausea
• Skin irritation and redness at the injection site
Common Side Effects
• Pneumonia
• Burning sensation during urination
• High fever
• Blood in urine and stool
• Seizures
• Lips swelling and Rashes
How To Use
Anti-cancer Injection Azalive should be given either intravenously or intramuscularly. Your doctor will determine the appropriate dosage and frequency of administration based on the severity of your condition, which may be subject to change. It is important to follow your doctor's instructions for taking Azalive 100 mg, as improper or excessive intake may lead to severe adverse effects. Although it may take several weeks or months to observe the benefits of the medication, it is essential not to discontinue treatment unless instructed to do so by your doctor.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Azalive 100 mg. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Anti-cancer Injection Azalive should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Azalive 100 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of Azacitidine 100 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Anti-cancer Injection Azalive. Azalive 100 mg may pass into breast milk and harm the infant. If you are breastfeeding and taking Azalive 100 mg Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Azacitidine 100 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Azalive 100 mg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Azalive 100 mg Vial may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Azalive 100 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Anti-cancer Injection Azalive during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Azalive 100 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Azalive Injection for cancer.